Literature DB >> 25163509

Fatal case of multiple recurrences of endometrial stromal sarcoma after fertility-sparing management.

Atsushi Morimoto1, Hiroshi Tsubamoto, Kayo Inoue, Yuuki Ikeda, Seiichi Hirota.   

Abstract

Several cases of the uterus being preserved after diagnosis of endometrial stromal sarcoma (ESS) have been reported. Most of these patients were alive and did not experience relapse, but this might have reflected the short follow-up period, given the indolent recurrence of ESS. We report the first fatal case of ESS 10 years after fertility-sparing management. A specimen obtained from the last operation showed loss of estrogen receptor status and expression of c-kit without c-kit or PDGFR-α gene mutations.
© 2014 The Authors. Journal of Obstetrics and Gynaecology Research © 2014 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  c-kit; endometrial stromal sarcoma; fertility-sparing management; leuprolide; recurrence

Mesh:

Year:  2014        PMID: 25163509     DOI: 10.1111/jog.12506

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  4 in total

1.  Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma.

Authors:  Weimin Xie; Dongyan Cao; Jiaxin Yang; Xuan Jiang; Keng Shen; Lingya Pan; Huifang Huang; Jinghe Lang; Yan You; Jie Chen
Journal:  Oncotarget       Date:  2017-02-07

Review 2.  Hormonal therapy in uterine sarcomas.

Authors:  Yuqin Zang; Mengting Dong; Kai Zhang; Chao Gao; Fei Guo; Yingmei Wang; Fengxia Xue
Journal:  Cancer Med       Date:  2019-03-21       Impact factor: 4.452

3.  Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature.

Authors:  Yawen Zheng; Qihui Yin; Xingsheng Yang; Ruiying Dong
Journal:  Ann Transl Med       Date:  2020-11

4.  Fertility-Sparing Management May Be Considered in Young Women with Uterine Sarcoma.

Authors:  Szymon Piątek; Iwona Szymusik; Anna Dańska-Bidzińska; Mariusz Ołtarzewski; Gabriela Trojan; Mariusz Bidziński
Journal:  J Clin Med       Date:  2022-08-15       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.